Richard W. Dugan is Director at Vanda Pharmaceuticals Inc. (VNDA). They have made 5 open-market trades across 1 company since 2015, most recently 2026-06-04.
CIK 0001263499
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VNDA | 219,054 | $850K |
Shares reported on the most recent Form 4, priced at the 2026-06-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VNDA | SELL | 2022-05-31 | 2022-06-02 | $9.85 | $64K | -4.4% | +16.4% | +7.1% |
| VNDA | SELL | 2021-02-16 | 2021-02-18 | $18.54 | $213K | -3.0% | -5.6% | -1.1% |
| VNDA | SELL | 2020-05-28 | 2020-05-29 | $11.04 | $224K | -6.7% | -4.0% | -10.4% |
| VNDA | SELL | 2019-08-26 | 2019-08-28 | $14.85 | $223K | -1.9% | -5.8% | +15.3% |
| VNDA | SELL | 2015-03-09 | 2015-03-10 | $10.69 | $51K | -4.3% | -1.1% | -1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.